UK begins trials of Ebola vaccine developed in just eight weeks
The UK medicines regulator has given approval for an experimental vaccine to be tested on healthy adults.
The UK medicines regulator has given approval for an experimental vaccine to be tested on healthy adults. The vaccine was developed in just eight weeks, a significant achievement in the fight against Ebola. The trial is expected to provide valuable insights into the vaccine's safety and efficacy. Researchers will closely monitor the participants' responses to the vaccine, gathering data to inform future development and potential use in clinical settings.